Forget the FAANGs - the top under-the-radar tech opportunities

Best hidden gems to get your teeth into

Investment Week
clock • 5 min read

The performance of tech stocks amid the market chaos caused by the coronavirus pandemic has been notable, with the performance of the giants of the sector Apple, Microsoft, Amazon, Alphabet and Facebook often single out by market commentators.

The performance of tech stocks amid the market chaos caused by the coronavirus pandemic has been notable, with the performance of the giants of the sector Apple, Microsoft, Amazon, Alphabet and Facebook often single out by market commentators.  However, while these stocks still dominate the headlines, investors continue to unearth appealing technology and related opportunities outside of the behemoths. Here, Investment Week speaks to several portfolio managers about their favourite under-the-radar tech opportunities. Jeremy Lang, partner and co-founder of Ardevora Asset Management,...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot